Affordable Access

deepdyve-link
Publisher Website

Borderline personality disorder, metacognition and psychotherapy.

Authors
  • D'Abate, Ludovica1
  • Delvecchio, Giuseppe2
  • Ciappolino, Valentina1
  • Ferro, Adele1
  • Brambilla, Paolo3
  • 1 Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' GrandaOspedale Maggiore Policlinico, Milan, Italy. , (Italy)
  • 2 Department of Pathophysiology and Transplantation, University of Milan, via F. Sforza 35, 20122 Milan, Italy. Electronic address: [email protected] , (Italy)
  • 3 Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' GrandaOspedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, via F. Sforza 35, 20122 Milan, Italy. , (Italy)
Type
Published Article
Journal
Journal of affective disorders
Publication Date
Jul 29, 2020
Volume
276
Pages
1095–1101
Identifiers
DOI: 10.1016/j.jad.2020.07.117
PMID: 32777647
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Deficits in the ability to think about own mental states and that of others (mindreading) are seen as key aspects of borderline personality disorder (BPD), which could sustain BPD symptoms. Interestingly, some studies showed that in BPD patients metacognition is selectively compromised and could improve during treatments. However, empirical findings are inconsistent, and it is debatable whether BPD presents a specific profile of mindreading impairments that could improve during treatments. We performed a bibliographic research on PubMed , Google Scholar and Scopus of all studies investigating a) the metacognitive functioning in the BPD patients and b) the link between psychotherapy, metacognition improvement and BPD symptomatology. A total of 11 studies met our inclusion criteria and considered metacognition following the definition proposed by Semerari. Overall, the results suggest that BPD metacognitive profile mainly includes difficulties in metacognitive sub-domains of integration, differentiation and mastery. The type of treatment most appropriate to improve metacognitive abilities and reduce symptoms seemed to be a long term treatment and specifically focused on metacognitive deficits. Lack of a control group, small sample sizes and heterogeneity in terms of gender, age, comorbidities and other ongoing treatments are the key limits of the original studies reviewed. The results sustain the hypothesis of a selective and specific metacognitive impairment in BPD patients that could improve during treatments together with their symptomatology. However, more studies are needed to further investigate the role of metacognition in the effectiveness of treatments. Copyright © 2020. Published by Elsevier B.V.

Report this publication

Statistics

Seen <100 times